🇺🇸 FDA
Patent

US 7329721

Maleamic acid polymer derivatives and their bioconjugates

granted A61KA61K47/60A61P

Quick answer

US patent 7329721 (Maleamic acid polymer derivatives and their bioconjugates) held by Nektar Therapeutics AL, Corporation expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics AL, Corporation
Grant date
Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K47/60, A61P, A61P11/00, A61P25/00